首页 > 最新文献

Current Opinion in Obstetrics & Gynecology最新文献

英文 中文
Management of missing intrauterine device strings and migrated intrauterine devices. 宫内节育器串缺失和宫内节育器移位的管理。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-08-21 DOI: 10.1097/GCO.0000000000000911
Stephanie I Amaya, Paul D Blumenthal

Purpose of review: The purpose of this review is to review the recent literature with respect to the management of missing intrauterine device (IUD) strings. As IUD use has increased over time, it is important to review management options for this uncommon but possible complication.

Recent findings: This article will cover stepwise approaches to management of missing IUD strings based on the most recent literature. Initial steps include obtaining history and using in office tools to reveal IUD strings. Subsequent steps focus on imaging guidelines including obtaining transvaginal ultrasound when available. Finally, IUD removal with tools for uterine instrumentation are discussed, focusing on using tools that do not require cervical dilation and allow for grasping of the device.

Summary: This paper details a stepwise approach to the management of missing IUD strings which, as discussed in the article, may become more frequent given the rise of IUD use in general and postpartum placement in specific.

综述目的:本综述的目的是回顾最近关于宫内节育器(IUD)管柱缺失管理的文献。由于宫内节育器的使用随着时间的推移而增加,因此审查这种罕见但可能出现的并发症的管理方案是很重要的。最近的发现:这篇文章将介绍基于最新文献的逐步方法来管理丢失的宫内节育器串。最初的步骤包括获取历史记录和使用办公室工具来揭示宫内节育器字符串。随后的步骤侧重于成像指南,包括在可用时获得经阴道超声。最后,讨论了使用子宫内固定工具取出宫内节育器的问题,重点是使用不需要宫颈扩张并允许抓握该装置的工具。摘要:本文详细介绍了一种逐步管理丢失宫内节育器串的方法,正如文章中所讨论的,随着宫内节育器在一般情况下的使用和产后放置的增加,这种方法可能会变得更加频繁。
{"title":"Management of missing intrauterine device strings and migrated intrauterine devices.","authors":"Stephanie I Amaya,&nbsp;Paul D Blumenthal","doi":"10.1097/GCO.0000000000000911","DOIUrl":"10.1097/GCO.0000000000000911","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to review the recent literature with respect to the management of missing intrauterine device (IUD) strings. As IUD use has increased over time, it is important to review management options for this uncommon but possible complication.</p><p><strong>Recent findings: </strong>This article will cover stepwise approaches to management of missing IUD strings based on the most recent literature. Initial steps include obtaining history and using in office tools to reveal IUD strings. Subsequent steps focus on imaging guidelines including obtaining transvaginal ultrasound when available. Finally, IUD removal with tools for uterine instrumentation are discussed, focusing on using tools that do not require cervical dilation and allow for grasping of the device.</p><p><strong>Summary: </strong>This paper details a stepwise approach to the management of missing IUD strings which, as discussed in the article, may become more frequent given the rise of IUD use in general and postpartum placement in specific.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"496-500"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10058522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mobile programs in family planning. 计划生育中的移动程序。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-08-21 DOI: 10.1097/GCO.0000000000000909
Simranvir Kaur, Eva Lathrop

Purpose of review: Mobile health outreach programs are an alternative way to provide family planning services for rural populations or populations affected by conflict, outbreaks, or humanitarian crises. Here, we review the current literature about mobile health outreach programs in family planning.

Recent findings: Mobile health outreach programs are effective in delivering family planning services by increasing access to family planning services including expanding method choice, contributing to resilient healthcare models, and advancing reproductive justice.Mobile health outreach programs may be a reasonable, cost saving, person-centered alternative to delivering healthcare particularly when traditional systems are strained.

Summary: Mobile health outreach programs in family planning exist in the United States and globally. Current literature suggests that mobile and outreach programs are effective in increasing knowledge and access to family planning in part by expanding method choice. A mobile health outreach approach is a resilient model that is person-centered and lends itself well to empower patients to practice self-care. The findings and lessons learned may be helpful in guiding future mobile health outreach programs in family planning and other services conducive to an out of clinic model, particularly as a response to overburdened health systems.

审查目的:流动卫生外展计划是为农村人口或受冲突、疫情或人道主义危机影响的人口提供计划生育服务的另一种方式。在这里,我们回顾了当前关于计划生育中流动健康外展项目的文献。最近的研究结果:移动健康外展计划通过增加获得计划生育服务的机会,有效地提供了计划生育服务,包括扩大方法选择,促进有弹性的医疗保健模式,以及促进生殖正义。移动健康外展计划可能是一种合理、节省成本、以人为中心的医疗保健替代方案,尤其是在传统系统紧张的情况下。摘要:美国和全球都有计划生育方面的流动健康外展项目。目前的文献表明,流动和外展计划在一定程度上通过扩大方法选择,有效地增加了计划生育的知识和机会。移动健康外展方法是一种以人为中心的弹性模式,有助于增强患者的自我护理能力。研究结果和经验教训可能有助于指导未来在计划生育和其他有助于诊所外模式的服务中的流动健康外展计划,特别是作为对负担过重的卫生系统的回应。
{"title":"Mobile programs in family planning.","authors":"Simranvir Kaur,&nbsp;Eva Lathrop","doi":"10.1097/GCO.0000000000000909","DOIUrl":"10.1097/GCO.0000000000000909","url":null,"abstract":"<p><strong>Purpose of review: </strong>Mobile health outreach programs are an alternative way to provide family planning services for rural populations or populations affected by conflict, outbreaks, or humanitarian crises. Here, we review the current literature about mobile health outreach programs in family planning.</p><p><strong>Recent findings: </strong>Mobile health outreach programs are effective in delivering family planning services by increasing access to family planning services including expanding method choice, contributing to resilient healthcare models, and advancing reproductive justice.Mobile health outreach programs may be a reasonable, cost saving, person-centered alternative to delivering healthcare particularly when traditional systems are strained.</p><p><strong>Summary: </strong>Mobile health outreach programs in family planning exist in the United States and globally. Current literature suggests that mobile and outreach programs are effective in increasing knowledge and access to family planning in part by expanding method choice. A mobile health outreach approach is a resilient model that is person-centered and lends itself well to empower patients to practice self-care. The findings and lessons learned may be helpful in guiding future mobile health outreach programs in family planning and other services conducive to an out of clinic model, particularly as a response to overburdened health systems.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"501-504"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10058524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation and management of urethral and periurethral masses in women. 女性尿道和尿道周围肿块的评估和处理。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-08-29 DOI: 10.1097/GCO.0000000000000914
Stephanie W Zuo, Gnankang Sarah Napoe

Purpose of review: Female periurethral masses are an uncommon occurrence. The purpose of this review is to describe etiologies of female urethral and periurethral masses and to provide an update on diagnosis and management.

Recent findings: The most common causes of periurethral and urethral masses in women are urethral caruncles, urethral diverticula, and Skene's gland cysts. Urethral meatal lesions such as urethral caruncles and prolapse can be managed conservatively with topical estrogen therapy and close follow-up or should be excised in the setting of thrombosis, significant or recurrent bleeding, acute urinary retention, or persistent pain. Benign periurethral gland masses, such as Skene's gland cysts, Gartner's duct cysts, and Mullerian duct cysts, remain rare. Recent case series reveal a high rate of surgical management of these lesions with few complications. Urethral malignancy or malignant transformation of benign etiologies are even rarer but can be aggressive in nature and should be treated promptly.

Summary: Nonspecific urinary and vaginal symptoms as well as similar physical presentations make diagnosis of urethral and periurethral lesions in females difficult. Magnetic resonance imaging is useful for differentiation of periurethral masses. The decision for conservative or surgical management is typically guided by patient symptom bother, as well as concern for urethral malignancy.

综述的目的:女性尿道周围肿块是一种罕见的发生。这篇综述的目的是描述女性尿道和尿道周围肿块的病因,并提供最新的诊断和治疗。最近的发现:女性尿道周围和尿道肿块最常见的原因是尿道肉阜、尿道憩室和Skene腺囊肿。尿道口病变,如尿道肉阜和脱垂,可以通过局部雌激素治疗和密切随访进行保守治疗,或者在血栓形成、严重或复发性出血、急性尿潴留或持续疼痛的情况下进行切除。良性尿道周围腺体肿块,如Skene腺囊肿、Gartner管囊肿和Mullerian管囊肿,仍然很少见。最近的病例系列显示,这些病变的手术治疗率很高,并发症很少。尿道恶性肿瘤或良性病因的恶变更为罕见,但其性质可能具有侵袭性,应及时治疗。摘要:非特异性的尿道和阴道症状以及类似的身体表现使女性尿道和尿道周围病变的诊断变得困难。磁共振成像有助于鉴别尿道周围肿块。保守治疗或手术治疗的决定通常以患者的症状困扰以及对尿道恶性肿瘤的担忧为指导。
{"title":"Evaluation and management of urethral and periurethral masses in women.","authors":"Stephanie W Zuo,&nbsp;Gnankang Sarah Napoe","doi":"10.1097/GCO.0000000000000914","DOIUrl":"10.1097/GCO.0000000000000914","url":null,"abstract":"<p><strong>Purpose of review: </strong>Female periurethral masses are an uncommon occurrence. The purpose of this review is to describe etiologies of female urethral and periurethral masses and to provide an update on diagnosis and management.</p><p><strong>Recent findings: </strong>The most common causes of periurethral and urethral masses in women are urethral caruncles, urethral diverticula, and Skene's gland cysts. Urethral meatal lesions such as urethral caruncles and prolapse can be managed conservatively with topical estrogen therapy and close follow-up or should be excised in the setting of thrombosis, significant or recurrent bleeding, acute urinary retention, or persistent pain. Benign periurethral gland masses, such as Skene's gland cysts, Gartner's duct cysts, and Mullerian duct cysts, remain rare. Recent case series reveal a high rate of surgical management of these lesions with few complications. Urethral malignancy or malignant transformation of benign etiologies are even rarer but can be aggressive in nature and should be treated promptly.</p><p><strong>Summary: </strong>Nonspecific urinary and vaginal symptoms as well as similar physical presentations make diagnosis of urethral and periurethral lesions in females difficult. Magnetic resonance imaging is useful for differentiation of periurethral masses. The decision for conservative or surgical management is typically guided by patient symptom bother, as well as concern for urethral malignancy.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"517-524"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10237837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current opinion: postpartum urinary disorders. 当前观点:产后泌尿系统疾病。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-09-29 DOI: 10.1097/GCO.0000000000000919
Shirley M Dong, Lisa C Hickman

Purpose of review: The aim of this study was to describe the common postpartum urinary sequelae including urinary retention and incontinence, and to summarize the management of these conditions.

Recent findings: Despite the high frequency of urinary disorders in obstetrics, screening and management protocols are rarely utilized by providers. Large variation exists in the literature regarding assessment of postpartum urinary retention, values of postvoid residuals and management of indwelling catheters in the immediate postpartum population. Recent expert guidance outlines a strategy for managing this condition.Research also highlights that screening for peripartum urinary incontinence is not a routine practice. The diagnosis is made more challenging by the fact that patients commonly understate and over-normalize their symptoms. Emerging studies have found that pelvic floor muscle training is cost-effective, preventive, and may improve symptoms in the postpartum setting.

Summary: Increased awareness of urinary disorders in pregnancy and postpartum is imperative for appropriate diagnosis and management. Instituting standardized voiding protocols postpartum will allow providers to avoid undiagnosed postpartum urinary retention and its repercussions. Improved screening and education regarding urinary incontinence in the peripartum is important for early management, such as pelvic floor muscle training, and improved quality of life.

综述目的:本研究的目的是描述常见的产后泌尿系统后遗症,包括尿潴留和失禁,并总结这些情况的处理方法。最近的发现:尽管产科中泌尿系统疾病的发生频率很高,但提供者很少使用筛查和管理方案。在产后人群中,关于产后尿潴留的评估、排尿后残余物的价值和留置导管的管理,文献中存在很大差异。最近的专家指南概述了管理这种情况的策略。研究还强调,筛查围产期尿失禁并不是一种常规做法。由于患者通常低估和过度正常化他们的症状,诊断变得更具挑战性。新兴研究发现,盆底肌肉训练具有成本效益、预防性,并可能改善产后症状。总结:提高对妊娠期和产后泌尿系统疾病的认识对于适当的诊断和管理至关重要。制定标准化的产后排尿方案将使提供者能够避免未经诊断的产后尿潴留及其影响。改善围产期尿失禁的筛查和教育对于早期管理(如盆底肌肉训练)和提高生活质量很重要。
{"title":"Current opinion: postpartum urinary disorders.","authors":"Shirley M Dong,&nbsp;Lisa C Hickman","doi":"10.1097/GCO.0000000000000919","DOIUrl":"10.1097/GCO.0000000000000919","url":null,"abstract":"<p><strong>Purpose of review: </strong>The aim of this study was to describe the common postpartum urinary sequelae including urinary retention and incontinence, and to summarize the management of these conditions.</p><p><strong>Recent findings: </strong>Despite the high frequency of urinary disorders in obstetrics, screening and management protocols are rarely utilized by providers. Large variation exists in the literature regarding assessment of postpartum urinary retention, values of postvoid residuals and management of indwelling catheters in the immediate postpartum population. Recent expert guidance outlines a strategy for managing this condition.Research also highlights that screening for peripartum urinary incontinence is not a routine practice. The diagnosis is made more challenging by the fact that patients commonly understate and over-normalize their symptoms. Emerging studies have found that pelvic floor muscle training is cost-effective, preventive, and may improve symptoms in the postpartum setting.</p><p><strong>Summary: </strong>Increased awareness of urinary disorders in pregnancy and postpartum is imperative for appropriate diagnosis and management. Instituting standardized voiding protocols postpartum will allow providers to avoid undiagnosed postpartum urinary retention and its repercussions. Improved screening and education regarding urinary incontinence in the peripartum is important for early management, such as pelvic floor muscle training, and improved quality of life.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"510-516"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41151979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial introductions. 编辑介绍。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-11-02 DOI: 10.1097/GCO.0000000000000921
{"title":"Editorial introductions.","authors":"","doi":"10.1097/GCO.0000000000000921","DOIUrl":"https://doi.org/10.1097/GCO.0000000000000921","url":null,"abstract":"","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"35 6","pages":"v"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Updates in contraception and abortion care: ghosts of the past, present, and future. 社论:避孕和堕胎护理的更新:过去、现在和未来的幽灵。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-11-02 DOI: 10.1097/GCO.0000000000000910
Paul D Blumenthal
{"title":"Editorial: Updates in contraception and abortion care: ghosts of the past, present, and future.","authors":"Paul D Blumenthal","doi":"10.1097/GCO.0000000000000910","DOIUrl":"10.1097/GCO.0000000000000910","url":null,"abstract":"","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"35 6","pages":"467-469"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical preparation for second-trimester procedural abortion. 妊娠中期手术流产的宫颈准备。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-08-30 DOI: 10.1097/GCO.0000000000000912
Farsam Fraz, Serena M Liu, Kate A Shaw

Purpose of review: To review the evidence-informed options for cervical preparation prior to second-trimester dilation and evacuation (D&E).

Recent findings: As abortion restrictions increase and the number of abortion clinics and providers decreases, pregnant people are facing more barriers to abortion access. Those in need are now often required to travel for second-trimester abortion care, only to be faced with additional restrictions, such as mandatory waiting periods. Cervical preparation is recommended prior to D&E and takes time for effect. Given the increasing time required to obtain an abortion, patients and providers may prefer same-day cervical preparation to decrease the total time required. Options for same-day cervical preparation include misoprostol alone with single or serial doses, and misoprostol combined with osmotic dilators or transcervical balloon (Foley catheter). Same-day preparation may require additional clinical space to accommodate people after initiation of cervical preparation to manage side-effects and timing of the abortion. Overnight options are also used and more frequently later in the second trimester. Overnight options include mifepristone, osmotic dilators, and transcervical balloon and are often combined with same-day misoprostol. Medication alone preparation is well tolerated and effective in the second trimester, with the addition of mechanical methods with advancing gestation. With many options and combinations being safe and effective, providers can be dynamic and alter approach with supply shortages, adjust to different clinical settings, consider patient medical and surgical factors, and accommodate provider and patient preferences.

Summary: Multiple pharmacologic and mechanical options have been shown to be safe and effective for cervical preparation prior to D&E. Consideration for multiple factors should influence the method of cervical preparation and methods may vary by patient, provider and setting.

审查目的:审查妊娠中期扩张和排空(D&E)前宫颈准备的循证选择。最近的研究结果:随着堕胎限制的增加和堕胎诊所和提供者的数量的减少,孕妇在堕胎方面面临着更多的障碍。现在,那些有需要的人经常被要求前往孕中期接受堕胎护理,但却面临额外的限制,例如强制性的等待期。建议在D&E之前进行宫颈准备,并且需要时间才能见效。考虑到堕胎所需时间的增加,患者和提供者可能更喜欢当天进行宫颈准备,以减少所需的总时间。当天宫颈准备的选择包括米索前列醇单次或连续给药,以及米索前列醇联合渗透扩张器或经宫颈球囊(Foley导管)。当天的准备工作可能需要额外的临床空间,以便在宫颈准备工作开始后容纳患者,以管理副作用和堕胎时间。过夜选项也被使用,并且在妊娠中期更频繁。过夜的选择包括米非司酮、渗透扩张器和经宫颈球囊,通常在当天与米索前列醇联合使用。单独的药物制剂在妊娠中期具有良好的耐受性和有效性,并添加了妊娠晚期的机械方法。由于许多选择和组合都是安全有效的,提供者可以是动态的,并在供应短缺的情况下改变方法,适应不同的临床环境,考虑患者的医疗和手术因素,并适应提供者和患者的偏好。总结:多种药物和机械选择已被证明对D&E前的宫颈准备是安全有效的。应考虑多种因素影响宫颈准备方法,方法可能因患者、提供者和环境而异。
{"title":"Cervical preparation for second-trimester procedural abortion.","authors":"Farsam Fraz,&nbsp;Serena M Liu,&nbsp;Kate A Shaw","doi":"10.1097/GCO.0000000000000912","DOIUrl":"10.1097/GCO.0000000000000912","url":null,"abstract":"<p><strong>Purpose of review: </strong>To review the evidence-informed options for cervical preparation prior to second-trimester dilation and evacuation (D&E).</p><p><strong>Recent findings: </strong>As abortion restrictions increase and the number of abortion clinics and providers decreases, pregnant people are facing more barriers to abortion access. Those in need are now often required to travel for second-trimester abortion care, only to be faced with additional restrictions, such as mandatory waiting periods. Cervical preparation is recommended prior to D&E and takes time for effect. Given the increasing time required to obtain an abortion, patients and providers may prefer same-day cervical preparation to decrease the total time required. Options for same-day cervical preparation include misoprostol alone with single or serial doses, and misoprostol combined with osmotic dilators or transcervical balloon (Foley catheter). Same-day preparation may require additional clinical space to accommodate people after initiation of cervical preparation to manage side-effects and timing of the abortion. Overnight options are also used and more frequently later in the second trimester. Overnight options include mifepristone, osmotic dilators, and transcervical balloon and are often combined with same-day misoprostol. Medication alone preparation is well tolerated and effective in the second trimester, with the addition of mechanical methods with advancing gestation. With many options and combinations being safe and effective, providers can be dynamic and alter approach with supply shortages, adjust to different clinical settings, consider patient medical and surgical factors, and accommodate provider and patient preferences.</p><p><strong>Summary: </strong>Multiple pharmacologic and mechanical options have been shown to be safe and effective for cervical preparation prior to D&E. Consideration for multiple factors should influence the method of cervical preparation and methods may vary by patient, provider and setting.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"470-475"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10552760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Medical abortion in the second trimester - an update. 妊娠中期药物流产-最新消息。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-12-01 Epub Date: 2023-10-09 DOI: 10.1097/GCO.0000000000000913
Helena Kopp Kallner
The safety and efficacy of medical abortion in the second trimester is provider independent and may therefore offer advantages over surgical second trimester abortion in certain settings. Due to bleeding risk, medical abortions in the second trimester are still mostly performed in a clinic or hospital setting. The most effective regimen for abortion includes pretreatment with oral mifepristone and following doses of misoprostol. An alternative is misoprostol only which should only be used when mifepristone is not available. The optimal dosing of prostaglandin to achieve the highest efficacy with the lowest proportion of complications remains to be established. Complications are rare and serious adverse events uncommon but may include uterine rupture especially in women with a previous cesarean delivery or uterine surgery. Women having second trimester medical abortion are a diverse group with different indications for the abortion. All women should be offered pain relief and respectful care. Staff involved in second trimester medical abortion often find their work challenging. At the same time, staff indicate pride and a conviction of contributing to the ‘greater good’ for women and society. Staff involved in second trimester abortion should be offered guidance and support through the employer. Post abortion contraception should be offered to all women having second trimester medical abortions, including those who have the abortion due to fetal malformation. All methods of contraception can be started immediately after a second trimester medical abortion except for cycle based methods and diaphragms.
妊娠中期药物流产的安全性和有效性与提供者无关,因此在某些情况下可能比妊娠中期手术流产更具优势。由于出血风险,妊娠中期的药物流产大多仍在诊所或医院进行。最有效的流产方案包括口服米非司酮预处理和随后剂量的米索前列醇。另一种选择是米索前列醇,只有在米非司酮不可用时才应使用。前列腺素的最佳剂量以达到最高疗效和最低并发症比例仍有待确定。并发症很少见,严重的不良事件也不常见,但可能包括子宫破裂,尤其是以前剖宫产或子宫手术的女性。妊娠中期药物流产的妇女是一个不同的群体,有不同的流产指征。所有妇女都应该得到止痛和尊重的照顾。从事妊娠中期药物流产的工作人员经常发现他们的工作具有挑战性。与此同时,工作人员表示自豪,并坚信为妇女和社会的“更大利益”做出贡献。应通过雇主为参与妊娠中期堕胎的工作人员提供指导和支持。堕胎后避孕应提供给所有进行中期药物流产的妇女,包括那些因胎儿畸形而堕胎的妇女。所有避孕方法都可以在妊娠中期药物流产后立即开始,但基于周期的方法和子宫内膜除外。
{"title":"Medical abortion in the second trimester - an update.","authors":"Helena Kopp Kallner","doi":"10.1097/GCO.0000000000000913","DOIUrl":"10.1097/GCO.0000000000000913","url":null,"abstract":"The safety and efficacy of medical abortion in the second trimester is provider independent and may therefore offer advantages over surgical second trimester abortion in certain settings. Due to bleeding risk, medical abortions in the second trimester are still mostly performed in a clinic or hospital setting. The most effective regimen for abortion includes pretreatment with oral mifepristone and following doses of misoprostol. An alternative is misoprostol only which should only be used when mifepristone is not available. The optimal dosing of prostaglandin to achieve the highest efficacy with the lowest proportion of complications remains to be established. Complications are rare and serious adverse events uncommon but may include uterine rupture especially in women with a previous cesarean delivery or uterine surgery. Women having second trimester medical abortion are a diverse group with different indications for the abortion. All women should be offered pain relief and respectful care. Staff involved in second trimester medical abortion often find their work challenging. At the same time, staff indicate pride and a conviction of contributing to the ‘greater good’ for women and society. Staff involved in second trimester abortion should be offered guidance and support through the employer. Post abortion contraception should be offered to all women having second trimester medical abortions, including those who have the abortion due to fetal malformation. All methods of contraception can be started immediately after a second trimester medical abortion except for cycle based methods and diaphragms.","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"490-495"},"PeriodicalIF":2.1,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49694176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skeletal muscle relaxants for the treatment of myofascial pelvic pain and high tone pelvic floor disorders. 骨骼肌松弛剂用于治疗骨盆肌筋膜疼痛和高音调盆底疾病。
IF 2.1 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-08-01 DOI: 10.1097/GCO.0000000000000894
Virginia Flatow, Jean Uy-Kroh, Erin T Carey, Charles Ascher-Walsh, Susan Khalil

Purpose of review: Chronic pelvic main is a complex process that includes many causes. In gynecology, the treatment of myofascial pelvic pain and high tone pelvic floor disorders can be managed with skeletal muscle relaxants for select clinical indications. A review of skeletal muscle relaxants will be included for gynecologic indications.

Recent findings: There are limited studies on vaginal skeletal muscle relaxants, but there can be oral forms used for chronic myofascial pelvic pain. They function as antispastic, antispasmodic, and combination of the two modes of action. Diazepam is the most studied for myofascial pelvic pain in both oral and vaginal formulations. Its use can be combined with multimodal management to optimize outcomes. Other medications have limitations due to dependency and limited studies that demonstrate improvement in pain scales.

Summary: Skeletal muscle relaxants have limited high quality studies for chronic myofascial pelvic pain. Their use can be combined with multimodal options to improve clinical outcomes. Additional studies are needed for vaginal preparations and evaluation of safety and clinical efficacy for patient reported outcomes measures in patients living with chronic myofascial pelvic pain.

综述目的:慢性盆腔炎是一个复杂的过程,包括许多原因。在妇科,肌筋膜盆腔疼痛和高音调盆底疾病的治疗可以用骨骼肌松弛剂治疗选定的临床适应症。骨骼肌松弛剂的审查将包括妇科适应症。最近发现:关于阴道骨骼肌松弛剂的研究有限,但可以口服形式用于慢性肌筋膜盆腔疼痛。它们的作用有抗痉挛、抗痉挛和两种作用方式的结合。地西泮是研究最多的肌筋膜盆腔疼痛在口服和阴道配方。它的使用可以与多模式管理相结合,以优化结果。其他药物由于依赖性和有限的研究证明疼痛程度的改善而有局限性。总结:骨骼肌松弛剂治疗慢性肌筋膜盆腔疼痛的高质量研究有限。它们的使用可与多模式选择相结合,以改善临床结果。对于患有慢性骨盆肌筋膜疼痛的患者,需要进一步的研究来进行阴道准备,以及评估其安全性和临床疗效。
{"title":"Skeletal muscle relaxants for the treatment of myofascial pelvic pain and high tone pelvic floor disorders.","authors":"Virginia Flatow,&nbsp;Jean Uy-Kroh,&nbsp;Erin T Carey,&nbsp;Charles Ascher-Walsh,&nbsp;Susan Khalil","doi":"10.1097/GCO.0000000000000894","DOIUrl":"https://doi.org/10.1097/GCO.0000000000000894","url":null,"abstract":"<p><strong>Purpose of review: </strong>Chronic pelvic main is a complex process that includes many causes. In gynecology, the treatment of myofascial pelvic pain and high tone pelvic floor disorders can be managed with skeletal muscle relaxants for select clinical indications. A review of skeletal muscle relaxants will be included for gynecologic indications.</p><p><strong>Recent findings: </strong>There are limited studies on vaginal skeletal muscle relaxants, but there can be oral forms used for chronic myofascial pelvic pain. They function as antispastic, antispasmodic, and combination of the two modes of action. Diazepam is the most studied for myofascial pelvic pain in both oral and vaginal formulations. Its use can be combined with multimodal management to optimize outcomes. Other medications have limitations due to dependency and limited studies that demonstrate improvement in pain scales.</p><p><strong>Summary: </strong>Skeletal muscle relaxants have limited high quality studies for chronic myofascial pelvic pain. Their use can be combined with multimodal options to improve clinical outcomes. Additional studies are needed for vaginal preparations and evaluation of safety and clinical efficacy for patient reported outcomes measures in patients living with chronic myofascial pelvic pain.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"35 4","pages":"311-315"},"PeriodicalIF":2.1,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gynecologic counseling for patients undergoing bariatric surgery: a scoping review. 为接受减肥手术的患者提供妇科咨询:范围界定综述。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2023-08-01 Epub Date: 2023-04-27 DOI: 10.1097/GCO.0000000000000878
Elizabeth Cook, Olga Fajardo, Rachel Lane Walden, Lara Harvey

Purpose of review: Obesity is associated with several gynecologic conditions. While bariatric surgery is regarded as the most effective treatment option for obesity, gynecologic counseling for patients planning bariatric surgery is limited and often focused on fertility. The goal of this scoping review is to investigate the current recommendations for gynecologic counseling prior to bariatric surgery.

Recent findings: A comprehensive search was conducted to find peer reviewed studies written in English discussing a gynecologic issue of patients who were planning or previously had bariatric surgery. All the included studies identified a gap in preoperative gynecologic counseling. The majority of the articles made specific recommendations for a multidisciplinary approach to preoperative gynecologic counseling with a call to involve gynecologists or primary care providers.

Summary: Patients deserve to receive appropriate counseling about how obesity and bariatric surgery impact their overall gynecologic health. We advocate that the scope of gynecologic counseling includes more than pregnancy and contraception counseling. We propose a gynecologic counseling checklist for female patients undergoing bariatric surgery. Offering patients a referral to a gynecologist from the patient's first entry to a bariatric clinic is imperative to facilitate appropriate counseling.

审查目的:肥胖与多种妇科疾病有关。虽然减肥手术被认为是治疗肥胖症最有效的方法,但为计划接受减肥手术的患者提供的妇科咨询却很有限,而且通常只关注生育问题。本范围综述旨在研究目前对减肥手术前妇科咨询的建议:我们进行了一次全面的检索,以找到用英语撰写的、讨论计划或曾经接受过减肥手术的患者的妇科问题的同行评审研究。所有收录的研究都指出了术前妇科咨询方面的不足。摘要:患者理应得到适当的咨询,了解肥胖和减肥手术对其整体妇科健康的影响。我们主张妇科咨询的范围不仅仅包括怀孕和避孕咨询。我们建议为接受减肥手术的女性患者制定一份妇科咨询清单。从患者第一次进入减肥诊所开始,就为其提供妇科医生转介服务,这对促进适当的咨询至关重要。
{"title":"Gynecologic counseling for patients undergoing bariatric surgery: a scoping review.","authors":"Elizabeth Cook, Olga Fajardo, Rachel Lane Walden, Lara Harvey","doi":"10.1097/GCO.0000000000000878","DOIUrl":"10.1097/GCO.0000000000000878","url":null,"abstract":"<p><strong>Purpose of review: </strong>Obesity is associated with several gynecologic conditions. While bariatric surgery is regarded as the most effective treatment option for obesity, gynecologic counseling for patients planning bariatric surgery is limited and often focused on fertility. The goal of this scoping review is to investigate the current recommendations for gynecologic counseling prior to bariatric surgery.</p><p><strong>Recent findings: </strong>A comprehensive search was conducted to find peer reviewed studies written in English discussing a gynecologic issue of patients who were planning or previously had bariatric surgery. All the included studies identified a gap in preoperative gynecologic counseling. The majority of the articles made specific recommendations for a multidisciplinary approach to preoperative gynecologic counseling with a call to involve gynecologists or primary care providers.</p><p><strong>Summary: </strong>Patients deserve to receive appropriate counseling about how obesity and bariatric surgery impact their overall gynecologic health. We advocate that the scope of gynecologic counseling includes more than pregnancy and contraception counseling. We propose a gynecologic counseling checklist for female patients undergoing bariatric surgery. Offering patients a referral to a gynecologist from the patient's first entry to a bariatric clinic is imperative to facilitate appropriate counseling.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"35 4","pages":"321-327"},"PeriodicalIF":2.2,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10573648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Obstetrics & Gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1